- Home
- AQST vs BETR Comparison
AQST vs BETR Comparison
Compare AQST & BETR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- BETR
- Stock Information
- Founded
- AQST 2004
- BETR 2014
- Country
- AQST United States
- BETR United States
- Employees
- AQST N/A
- BETR N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- BETR Finance: Consumer Services
- Sector
- AQST Health Care
- BETR Finance
- Exchange
- AQST Nasdaq
- BETR Nasdaq
- Market Cap
- AQST 272.9M
- BETR 218.6M
- IPO Year
- AQST 2018
- BETR N/A
- Fundamental
- Price
- AQST $4.07
- BETR $13.71
- Analyst Decision
- AQST Strong Buy
- BETR
- Analyst Count
- AQST 7
- BETR 0
- Target Price
- AQST $11.29
- BETR N/A
- AVG Volume (30 Days)
- AQST 1.3M
- BETR 104.4K
- Earning Date
- AQST 08-05-2025
- BETR 08-07-2025
- Dividend Yield
- AQST N/A
- BETR N/A
- EPS Growth
- AQST N/A
- BETR N/A
- EPS
- AQST N/A
- BETR N/A
- Revenue
- AQST $54,228,000.00
- BETR $118,790,000.00
- Revenue This Year
- AQST N/A
- BETR N/A
- Revenue Next Year
- AQST $45.71
- BETR N/A
- P/E Ratio
- AQST N/A
- BETR N/A
- Revenue Growth
- AQST 5.29
- BETR 56.38
- 52 Week Low
- AQST $2.12
- BETR $7.71
- 52 Week High
- AQST $5.80
- BETR $30.00
- Technical
- Relative Strength Index (RSI)
- AQST 72.86
- BETR 55.31
- Support Level
- AQST $3.62
- BETR $13.08
- Resistance Level
- AQST $3.80
- BETR $13.80
- Average True Range (ATR)
- AQST 0.19
- BETR 0.77
- MACD
- AQST 0.05
- BETR 0.15
- Stochastic Oscillator
- AQST 95.43
- BETR 65.69
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About BETR Better Home & Finance Holding Company
Better Home & Finance Holding Co is a digital-first homeownership company whose services include mortgage, real estate, title, and homeowners insurance. The company has combined technology innovation and fresh thinking with a deep customer focus with the goal of revolutionizing the homeownership industry.